制药在线首页

询盘篮(0) 帮助 搜全站 搜本商铺
  • 公司概况
  • 成立年份: 2005

  • 总资产(USD): 80,000,000至84,999,999

  • 员工总人数: 500以上

  • 主要竞争优势: 品牌,国际认证/标准,经验丰富的研发人员,发货速度,生产能力,产品线丰富,合同定制,接受买家的规格要求,接受小额订单,良好的信誉,优质服务

  • 其他竞争优势: 百合股份拥有成熟的销售网络,主要由合同生产销售渠道、经销渠道、线下直营渠道和线上直营渠道构成。公司营销网络覆盖了消费者所能接触的主要渠道,能够避免渠道单一而出现的销售渠道依赖风险,形成了公司的销售网络优势。 在合同生产渠道方面,凭借前瞻性的产品研发以及对国内外市场的深刻了解,公司已与国内外多家知名营养保健食品品牌运营商合作建立了长期稳固的战略合作关系,与国内外知名品牌的合作提升了公司的知名度与行业地位,吸引着更多的客户与公司合作。 在自主品牌渠道方面,公司与大参林、益丰大药房、老百姓大药房、重庆万和、贵州一树等百强连锁药店直接或间接建立了合作关系,也与吉林大药房、辽宁人民康泰大药房、江西德融药房、山西仁和大药房等多家区域性连锁药店保持密切合作。同时,公司产品还进驻了京东、天猫、苏宁等大型电商平台。截至2021 年 6 月 30 日,公司营销网络已覆盖全国 30 多个省市自治区,公司产品销往美国、欧洲等 60 多个国家和地区。 The company has a mature sales network, which is mainly composed of contract production sales channels, distribution channels, offline direct sales channels and online direct sales channels. The company's marketing network covers the main channels that consumers can access, which can avoid the risk of relying on sales channels due to a single channel, and form the company's sales network advantages. In terms of contract production channels, with forward-looking product research and development and a deep understanding of domestic and foreign markets, the company has established long-term and stable strategic cooperative relations with many well-known nutritional and health food brand operators at home and abroad. The cooperation with well-known brands at home and abroad has enhanced the company's popularity and industry status, attracting more customers to cooperate with the company. In terms of independent brand channels, the company has directly or indirectly established cooperative relationships with multiple chain pharmacies such as Dashenlin, Yifeng Pharmacy, Common People Pharmacy, Chongqing Wanhe, Guizhou Yishu, etc. A number of regional chain pharmacies such as Big Pharmacy, Jiangxi Derong Pharmacy, Shanxi Renhe Pharmacy and so on have maintained close cooperation. At the same time, the company's products have also entered large e-commerce platforms such as JD.com, Tmall, and Suning. As of June 30, 2021, the company's marketing network has covered more than 30 provinces, municipalities and autonomous regions across the country, and the company's products are sold to more than 70 countries and regions including the United States and Europe.

  • 专利与版权

  • 业务概况
  • 业务类型: 制造商,出口商,进口商,零售商

  • 年销售额(USD): 不愿意公开

  • 主要销售市场: 北美洲,中/南美洲,西欧,东欧,亚洲,中东,非洲

  • 主要产品类别: 中间体,生物制品,天然提取物,合同外包、定制服务及咨询

  • 所有产品: soft capsules, hard capsules, tablets, powders, granules, oral liquids, drops, bottle drinks and soft drinks

  • 外销比重

  • 内销比重

  • 主要客户

  • 其它信息
  • 合同定制: CRO,CMO

  • 付款条款

公司详情

威海百合生物技术股份有限公司成立于2005年,先后通过了美国NSF工厂认证、美国FDA注册、英国BRCGS认证、HACCP认证、欧盟水产品注册,加拿大FSRN注册、社会责任Smeta认证等国内外知名管理体系认证或注册。可生产软胶囊、硬胶囊、片剂、粉剂、颗粒剂、口服液、滴剂、瓶饮、软饮等10余种剂型,4000余种营养保健食品,现有保健食品文号六百余个,产品出口欧美等60余个国家和地区,致力于以优质产品持续领跑行业。

威海百合认为,创新产品能够大大留存用户,保持优良品质经受得住消费者以及时间的考验。故而威海百合决定从传统工厂到智能化工厂方向发展,运用产品数字化、生产数字化、设备数字化、管理数据化,实以实现“6个1”数字化管理目标。同时威海百合还建有CNAS实验室认可标准的检测中心,拥有专业的研发团队,同时与中科院、中国海洋大学等多个知名高校合作,不断加大研发投入,根据消费者的需求,对自身的产品进行创新。

如今的威海百合已经拥有从研发、法规、生产、检测、质量管理到采购、仓储、物流,八大部门建立的强大供应链管理,致力打造全球领先的营养食品生产加工基地。

Weihai Baihe Biotechnology Co., Ltd. (hereinafter referred to as "Biohigh"), established in November 2005, is one of the leading national high-tech company specializing in the research, development, production and sales of nutrition and health food. Listed on the main board of the Shanghai Stock Exchange in January 2022, stock code: 603102, it is the first stock listed on the main board of the nutrition and health food industry.

Biohigh has a high level of large-scale production capacity in the field of nutrition and health food manufacturing with an international advanced automated production system, which is linked through ERP, MES, WMS, SRM intelligent information systems. Based on that system, the company can conduct in-depth data exchange and interconnection, quickly respond to market demands, and improve delivery rates.

Biohigh owns 2 main GMP factories, covering an area of 300 mu (20 hectares) and 20,000 GMP workshops, with over 1000 employees, which can produce more than 10 dosage forms such as soft capsules, hard capsules, tablets, powders, granules, oral liquids, drops, bottle drinks and soft drinks. The daily production capacity of all products has exceeded 3 million bottles (boxes, bags).

Biohigh has successively received the multiple quality management system certifications and registration of well-known trademarks, such as ISO quality certifications, NSF, US FDA Registration, EU fishery Registration No., BRCGS, HACCP, FSRN, Smeta, etc. The products are exported to more than 70contries all over the world

R&D innovation is the core driving force for Biohigh's rapid development, and the annual R&D investment exceeds 3.6% of sales revenue. It has applied for more than 200 patents successively, and has obtained a number of production qualifications such as health food, general food, supplementary food for pregnant and infants, and sports nutrition. Every year, more than 400 new products are launched, and more than 700 health food approvals are held.

Biohigh has always believed that quality is the foundation for the sustainable development of an enterprise. The company has a testing center that meets the requirements of CNAS standards, more than 120 sets of imported testing equipment, and more than 400 testing items. In terms of process control, the company has continuously improved the quality management system and product traceability system, and established 14 quality control points to strictly control the life quality of each product.

To be a respected enterprise, to be a product of conscience and quality of life -Biohigh is committed to improving and protecting people’s health.

里程碑

威海百合生物科技有限公司成立于2005年,是一家以海洋生物研发为主,专业生产膳食营养补充剂的股份制企业。也是亚洲最大的膳食营养补充剂生产基地。

威海市当地近年来兴起诸多以海洋经济为主题的企业,其中威海百合生物技术股份有限公司是其中极具代表性的企业之一。它代表着20余年来我国沿海城市内海洋产品生产企业的发展的路程。

在建企后的20多年里,百合生物依托丰富的海洋资源,从一个11人的小工厂发展到拥有1000余人的全球最大营养补充剂生产基地。

依托独有海洋资源优势,百合人树立了“科技兴海”的发展战略,以科技向海洋索取效益。20年来百合生物专注营养保健食品生产研发,依靠远洋捕捞优势从远洋捕捞、压榨、精炼、分子蒸馏、鱼油软胶囊等实现了一条龙生产,将鱼油的DHA和EPA精练到90%以上,这是中国鱼油发展的标志性里程碑。不仅如此,百合生物还参与起草制定了国家《多烯鱼油及制品》质量标准,被公认为全国鱼油生产第一家企业。

Weihai Baihe Biotechnology Co., Ltd. was established in 1996. It is a joint-stock enterprise specializing in the research and development of marine organisms and specializing in the production of dietary nutritional supplements. It is also the largest production base of dietary supplements in Asia.

In recent years, many enterprises with the theme of marine economy have emerged in Weihai City, among which Weihai Baihe Biotechnology Co., Ltd. is one of the most representative enterprises. It represents the development of marine product manufacturers in coastal cities in my country for more than 20 years.

In the more than 20 years since its establishment, the comoany has grown from a small factory with 11 employees to the world's largest nutritional supplement production base with more than 1,000 employees, relying on abundant marine resources.

Relying on the unique advantages of marine resources, Baihe people have established the development strategy of "rejuvenating the sea with science and technology", and seek benefits from the ocean with science and technology. In the past 20 years, the company has been focusing on the production and development of nutritional and health food, relying on the advantages of pelagic fishing to achieve one-stop production from pelagic fishing, pressing, refining, molecular distillation, fish oil soft capsules, etc., and refining the DHA and EPA of fish oil to more than 90%. In April 1996, China's first bottle of polyene fish oil soft capsule was born, which is a landmark milestone in the development of fish oil in China. Not only that, the company also participated in the drafting and formulation of the national "polyene fish oil and products" quality standard, which is recognized as the first enterprise in the country to produce fish oil.

联系我们
  • 威海百合生物技术股份有限公司
    威海百合生物技术股份有限公司
  • 公司地址:

    山东省荣成市天鹅湖经济技术开发区

  • 公司网址:

    myImage

快速询盘
友情链接
最近更新日期: 2024年04月16日 违规举报 订阅产品资讯
CPHI 网上贸易平台: CPHI.cn| Pharmasources.com| CPHI-Online.com
客服热线:  86-400 610 1188 (周一至周五 9: 00-18: 00)